Overlooked molecule might be key to how well CAR-T cells work - STAT

Overlooked molecule might be key to how well CAR-T cells work - STAT

Overlooked molecule might be key to how well cancer-fighting CAR-T cells work

By SHARON BEGLEY

ODRA NOEL/WELLCOME COLLECTION

The component is called the co-stimulatory domain, and the two CAR-T therapies approved last year — Yescarta and Kymriah — use different ones.

READ MORE